113 related articles for article (PubMed ID: 34406989)
1. Identification of the expression of farnesoid X receptor in astrocytes.
He H; Chen Z; Chen D; Lu X; Huang C; Chen J
Neuroreport; 2021 Oct; 32(14):1216-1222. PubMed ID: 34406989
[TBL] [Abstract][Full Text] [Related]
2. Identification of functional farnesoid X receptors in brain neurons.
Huang C; Wang J; Hu W; Wang C; Lu X; Tong L; Wu F; Zhang W
FEBS Lett; 2016 Sep; 590(18):3233-42. PubMed ID: 27545319
[TBL] [Abstract][Full Text] [Related]
3. Activation of FXR pathway does not alter glial cell function.
Albrecht S; Fleck AK; Kirchberg I; Hucke S; Liebmann M; Klotz L; Kuhlmann T
J Neuroinflammation; 2017 Mar; 14(1):66. PubMed ID: 28351411
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver.
Wang B; Zhang H; Luan Z; Xu H; Wei Y; Zhao X; Xing M; Huo X; Zhang J; Su W; Guan Y; Zhang X
Exp Cell Res; 2020 May; 390(1):111949. PubMed ID: 32145254
[TBL] [Abstract][Full Text] [Related]
5. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X receptor knockout protects brain against ischemic injury through reducing neuronal apoptosis in mice.
Shan HM; Zang M; Zhang Q; Shi RB; Shi XJ; Mamtilahun M; Liu C; Luo LL; Tian X; Zhang Z; Yang GY; Tang Y; Pu J; Wang Y
J Neuroinflammation; 2020 May; 17(1):164. PubMed ID: 32450881
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
[TBL] [Abstract][Full Text] [Related]
10. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
[TBL] [Abstract][Full Text] [Related]
11. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
[TBL] [Abstract][Full Text] [Related]
12. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
[TBL] [Abstract][Full Text] [Related]
13. FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake.
Li L; Zhao H; Chen B; Fan Z; Li N; Yue J; Ye Q
J Transl Med; 2019 Dec; 17(1):418. PubMed ID: 31836014
[TBL] [Abstract][Full Text] [Related]
14. The Status of Bile Acids and Farnesoid X Receptor in Brain and Liver of Rats with Thioacetamide-Induced Acute Liver Failure.
Czarnecka AM; Milewski K; Albrecht J; Zielińska M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092050
[TBL] [Abstract][Full Text] [Related]
15. Antiatherosclerotic effect of farnesoid X receptor.
Mencarelli A; Renga B; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
[TBL] [Abstract][Full Text] [Related]
16. Interactions between Atorvastatin and the Farnesoid X Receptor Impair Insulinotropic Effects of Bile Acids and Modulate Diabetogenic Risk.
Hoffmeister T; Kaiser J; Lüdtke S; Drews G; Düfer M
Mol Pharmacol; 2020 Mar; 97(3):202-211. PubMed ID: 31911428
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
[TBL] [Abstract][Full Text] [Related]
18. Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α.
Dwivedi SK; Singh N; Kumari R; Mishra JS; Tripathi S; Banerjee P; Shah P; Kukshal V; Tyagi AM; Gaikwad AN; Chaturvedi RK; Mishra DP; Trivedi AK; Sanyal S; Chattopadhyay N; Ramachandran R; Siddiqi MI; Bandyopadhyay A; Arora A; Lundåsen T; Anakk SP; Moore DD; Sanyal S
Mol Endocrinol; 2011 Jun; 25(6):922-32. PubMed ID: 21493670
[TBL] [Abstract][Full Text] [Related]
19. Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo.
Mroz MS; Keating N; Ward JB; Sarker R; Amu S; Aviello G; Donowitz M; Fallon PG; Keely SJ
Gut; 2014 May; 63(5):808-17. PubMed ID: 23916961
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury.
Pu J; Yuan A; Shan P; Gao E; Wang X; Wang Y; Lau WB; Koch W; Ma XL; He B
Eur Heart J; 2013 Jun; 34(24):1834-45. PubMed ID: 22307460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
